[{"indications": "Indications\u00a0reversible airways obstruction, severe\r\nacute asthma", "name": "AMINOPHYLLINE Modified release", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "3 Respiratory system", "3.1 Bronchodilators", "3.1.3 Theophylline", "AMINOPHYLLINE", "Modified release"], "cautions": "Cautions\u00a0see under Theophylline", "side-effects": "Side-effects\u00a0see under Theophylline; also allergy to ethylenediamine can cause urticaria, erythema,\r\nand exfoliative dermatitis; hypotension, arrhythmias, and convulsions\r\nespecially if given rapidly by intravenous injection", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/2943.htm", "doses": ["See under preparations, below", "Plasma-theophylline concentration\r\nfor optimum response 10\u201320\u00a0mg/litre (55\u2013110\u00a0micromol/litre); measure\r\nplasma-theophylline concentration 4\u20136 hours after dose by mouth and\r\nat least 5 days after starting oral treatment; measure plasma-theophylline\r\nconcentration 4\u20136 hours after the start of intravenous infusion; narrow\r\nmargin between therapeutic and toxic dose, see also notes above", "To avoid excessive dosage\r\nin obese patients, dose should be calculated on the basis of ideal\r\nweight for height", "initially 1 tablet twice daily, increased after 1 week\r\nto 2 tablets twice daily if necessary", "Name[Phyllocontin Continus\u00ae (Napp)] Tablets, m/r, yellow, f/c, aminophylline hydrate 225\u00a0mg, net price 56-tab pack = \u00a32.39. \r\n    Label:\r\n    25Dose\u00a0adult and child body-weight over 40\u00a0kg initially 1 tablet twice\r\ndaily, increased after 1 week to 2 tablets twice daily according to\r\nplasma-theophylline concentration\nForte tablets, m/r, yellow, f/c, aminophylline hydrate 350\u00a0mg, net price 56-tab pack = \u00a34.22. \r\n    Label:\r\n    25Dose\u00a0initially 1 tablet twice daily, increased after 1 week\r\nto 2 tablets twice daily if necessaryNote\u00a0Phyllocontin Continus\u00ae Forte tablets are for smokers and other patients with shorter theophylline half-life (see notes above)"], "pregnancy": "Pregnancy\u00a0see under Theophylline"}, {"indications": "Indications\u00a0reversible airways obstruction, severe\r\nacute asthma", "name": "AMINOPHYLLINE", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "3 Respiratory system", "3.1 Bronchodilators", "3.1.3 Theophylline", "AMINOPHYLLINE"], "cautions": "Cautions\u00a0see under Theophylline", "side-effects": "Side-effects\u00a0see under Theophylline; also allergy to ethylenediamine can cause urticaria, erythema,\r\nand exfoliative dermatitis; hypotension, arrhythmias, and convulsions\r\nespecially if given rapidly by intravenous injection", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/2941.htm", "doses": ["See under preparations, below", "Plasma-theophylline concentration\r\nfor optimum response 10\u201320\u00a0mg/litre (55\u2013110\u00a0micromol/litre); measure\r\nplasma-theophylline concentration 4\u20136 hours after dose by mouth and\r\nat least 5 days after starting oral treatment; measure plasma-theophylline\r\nconcentration 4\u20136 hours after the start of intravenous infusion; narrow\r\nmargin between therapeutic and toxic dose, see also notes above", "To avoid excessive dosage\r\nin obese patients, dose should be calculated on the basis of ideal\r\nweight for height"], "pregnancy": "Pregnancy\u00a0see under Theophylline"}]